Net loss (GAAP) increased by $5,600,000 to $16,600,000 for the fiscal third quarter ended June 30, 2025, reflecting a ...

Q2 2025 Management View Jack Dorsey stated the company is "back to growth mode across the company," highlighting increased product velocity and the rapid pace of feature launches, including Pools and ...

Mike Cannon-Brookes has held a powerful voting stake in the software giant, equal to his co-founder Scott Farquhar’s. His ...

Learn how to prepare Quant for IB SA 2025 with Class 10 basics, daily practice, topic-wise strategy, mock tests, and tips to ...

Q2 2025 earnings reveal progress in debt reduction, sports growth, and margin gains, despite ad market challenges.

Michael J. Sardano, President, detailed execution on the three-pronged strategy: “increase patient awareness for SRT, grow internationally and advance our pipeline.” He spotlighted the MDSAP ...

Operator: Greetings, and welcome to the Fulgent Genetics Q2 2025 Conference Call and Webcast. [Operator Instructions] As a ...

Q2 2025 Management View Kevin James Leidwinger, President and CEO, highlighted, "UFG delivered strong results in the second ...

Adjusted EBITDA (Q4): Adjusted EBITDA loss of $316,000 for Q4 FY2025, substantially narrowed from a $1.7 million adjusted ...

Madras High Court ruled that income tax reassessment based on information already available in audited financial statements is invalid, finding no failure by the company to disclose material ...

NCS’s Chief Executive Officer, Ryan Hummer commented, "Our team at NCS has continued to enable strong operational and financial performance in an industry and market environment marked by uncertainty.

Australian Agricultural Co annual general meetings are often pretty tame affairs, but some robust exchanges between ...